BioLineRx Ltd. (BLRX) Operating cash flow 2016–2025
BioLineRx Ltd. (BLRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.1MFY2025 · since FY2016: -$14.5M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.1M | +81.6% |
| FY2024 | -$43.9M | -94.1% |
| FY2023 | -$22.6M | +13.8% |
| FY2022 | -$26.2M | -11.3% |
| FY2021 | -$23.6M | -1.6% |
| FY2020 | -$23.2M | -2.4% |
| FY2019 | -$22.7M | +6.3% |
| FY2018 | -$24.2M | -17.7% |
| FY2017 | -$20.5M | -41.6% |
| FY2016 | -$14.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice